SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that Jacquelyn Powers, M.S., LCGC, of the Hospital of the University of Pennsylvania, and Ofri Leitner, M.S., CGC, of the University of North Carolina at Chapel Hill, have joined Pathway Genomics’ strategic advisory board. Powers and Leitner are well-respected clinical genetic counselors that are intimately involved in the hereditary cancer programs at their respective institutions.
“We look forward to Ms. Powers and Ms. Leitner’s thoughtful clinical input on our current products, as well as their insight into our future testing services,” said Ardy Arianpour, Pathway Genomics’ chief commercial officer.
Powers is a licensed genetic counselor who currently works in the division of hematology-oncology at the Abramson Cancer Center at the University of Pennsylvania where she manages the facilitation of risk assessment and genetic testing for heritable breast, ovarian, and gastrointestinal cancer syndromes.
As the project manager for Penn’s IMPACT study (Identification of Men with a Genetic Predisposition to Prostate Cancer: Targeted Screening in BRCA1/2 Mutation Carriers and Controls) study, Powers is also closely involved in the development and implementation of a novel genetic counseling model that addresses the rapidly evolving area of clinical genetic testing for inherited cancer susceptibility. She previously served as co-chair of the communications sub-committee for the National Society of Genetic Counselors and is currently completing her second year with St. Joseph’s University’s Contemplative Leaders in Action (CLA).
Leitner is a board certified genetic counselor and clinical assistant professor of genetics at the University of North Carolina at Chapel Hill where she counsels individuals at increased risk of hereditary conditions at a variety of clinics including: the Cancer Genetics clinic, Hereditary Hemorrhagic Telangiectasia Center of Excellence, which she helped establish, and the Muscular Dystrophy Association clinic. In addition to her clinical activities, Leitner is a supervisor and mentor to genetic counseling graduate students and participates in various lectures for medical students, undergraduates and high-school students. Prior to joining UNC at Chapel Hill, she held positions at the Virginia G. Piper Cancer Center in Arizona, and at the Soronka University Medical Center’s Genetics Institute in Israel.
About Pathway Genomics Corporation
As a CLIA and CAP accredited clinical laboratory based in San Diego, California, Pathway Genomics provides physicians and their patients with actionable and accurate genetic information to improve or maintain health and wellness. Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation and commitment to medical responsibility – making it a leader in the commercial genetic testing industry. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com.